Sponsor or institution
Clinical trials and research at CNBG-Virogin Biotech (Shanghai) Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by CNBG-Virogin Biotech (Shanghai) Ltd. that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Treatment of advanced intrahepatic cholangiocarcinoma with VG161
This study is testing a new injectable treatment called VG161 for people with advanced bile duct cancer who haven't had success with other therapies to see if it can help shrink their tumors.
-
Treatment of advanced bone and soft tissue sarcoma with VG161 injections
This study is testing if VG161 injections can help people with advanced bone and soft tissue sarcoma who haven't responded to other treatments.
Quick answers
How many clinical trials run by CNBG-Virogin Biotech (Shanghai) Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.